[CDAGS syndrome (craniostenosis, deafness, anal abnormalities and genitourinary malformations with skin rash)].

Syndrome CDAGS (craniosténose, surdité, anomalie anale et génito-urinaire avec éruption cutanée).

Journal

Annales de dermatologie et de venereologie
ISSN: 0151-9638
Titre abrégé: Ann Dermatol Venereol
Pays: France
ID NLM: 7702013

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 23 02 2020
revised: 07 07 2020
accepted: 16 07 2020
pubmed: 4 11 2020
medline: 16 10 2021
entrez: 3 11 2020
Statut: ppublish

Résumé

CDAGS syndrome (craniosynostosis, deafness, anal and genitourinary abnormality with rash) has been reported in 8 families of different geographical origins since 1981. No genes have been identified to date. The patient is a girl born at 40 weeks of amenorrhea after a normal pregnancy. She was born to non-consanguineous parents and there was no significant family history. At birth, she presented craniosynostosis with a form of premature coronal suture. When she was 3 months old, she presented an eczematous facial rash. At 11 months, a skin biopsy showed lichenoid dermatosis with epidermal atrophy associated with ortho- and para-keratotic hyperkeratosis. She had sparse hair, eyelashes and eyebrows. Her initial psychomotor development was normal. No other malformations were observed. At 6 years, she presented pale pink, reticulated, erythematous plaques around healthy bands of skin on her throat and chin. Lesions on the elbows, knees and buttocks were linear and keratotic with no atrophy or telangiectasia. At 7 years, she had learning difficulties and delayed speech. Genetic assessment revealed no abnormalities. The specific dermatologic aspect combined with craniosynostosis suggested a possible diagnosis of CDAGS syndrome, even in the absence of urogenital or anal lesions. This syndrome may take numerous different forms. The appearance of porokeratosis previously noted was not found here. The underlying genetic substratum of this syndrome is not known as yet and additional genetic studies should be considered.

Identifiants

pubmed: 33139060
pii: S0151-9638(20)31044-9
doi: 10.1016/j.annder.2020.10.016
pii:
doi:

Types de publication

Case Reports

Langues

fre

Sous-ensembles de citation

IM

Pagination

868-872

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

R Cohen-Sors (R)

Service de dermatologie, CHU d'Amiens-Picardie, 2, place Victor-Pauchet, 80000 Amiens, France. Electronic address: raphaella.cs@hotmail.fr.

B Devauchelle (B)

Service de chirurgie maxillo-faciale, CHU Amiens-Picardie - Site Sud, 1, Rond-Point du Professeur-Christian-Cabrol, 80000 Amiens, France.

P Vabres (P)

Service de dermatologie, CHU de Dijon, 14, rue Paul-Gaffarel, 21000 Dijon, France.

M Jain (M)

Service de génétique humaine et moléculaire, Baylor College of Medicine, Houston, Texas, USA; Institut Kennedy Krieger, Université Johns Hopkins, Baltimore, Maryland, USA.

B Demeer (B)

Centre de génétique, CLAD Nord Ouest, CHU Amiens-Picardie, EA7516-CHIMERE, Université Picardie Jules-Verne, Institut Faire-Face Amiens, Amiens, France.

E Carmi (E)

Cabinet de dermatologie, 34, avenue d'Allemagne, 80000 Amiens, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH